<p>Merus NV has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission, naming Genmab A/S as the beneficial owner. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merus NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-325257), on December 18, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

MRUS

<p>Merus NV has filed a statement with the SEC, naming Genmab A/S as a 10% beneficial owner. This filing is accessible via EDGAR, and Merus NV is responsible for the information. The news was generated by Public Technologies using AI and is not financial advice.</p>

Merus NV Files Initial Beneficial Ownership Statement Naming Genmab A/S as 10% Owner